Biopharmaceutical news organization Endpoints News announced Tuesday that Drew Armstrong has been hired as executive editor.
He starts Nov. 9.
In this newly created role, Armstrong will lead the editorial team and help direct the company into premium news and subscription data products, new events and tools for connecting the biopharma world. He will also join the board of directors.
Armstrong was most recently Bloomberg’s senior editor for health care. During his more than 12 years there, he led the newsroom’s U.S. coverage of the COVID-19 pandemic, developed its “Prognosis” health care vertical and managed a team of a dozen journalists covering the American health care system.
He also led development of the Bloomberg Vaccine Tracker, a global data tool read by millions of people, and his writing and editing have been acknowledged in multiple journalism awards.
Endpoints revenue has nearly tripled in the last three years, and it is expanding into related verticals and adding new products of value to its highly specialized audience. Founded in 2016, it has over 152,000 daily subscribers, 700 corporate subscription licenses, and a team of journalists and staff in the U.S., Europe and Asia.
“We have grown from a startup to become an integral part of the healthcare world. Drew’s appointment marks a major step in our evolution,” said Endpoints founder and co-CEO John Carroll, who will continue to write, organize and host events around the world, live and online.